Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Brain Cancer Statistics

Brain Cancer Statistics on Survival Rates

Survival rates can be calculated by different methods for different purposes. The brain cancer survival rates presented here are based on the relative survival rate. The relative survival rate measures the survival of the brain cancer patients in comparison to the general population to estimate the effect of cancer. The overall 5-year relative brain cancer survival rate for 1995-2001 was 33.3 percent.
 
The 5-year relative survival rates for brain cancer by race and sex were as follows:
 
  • 32.1 percent for Caucasian men
  • 33.5 percent for Caucasian women
  • 37.7 percent for African-American men
  • 37.5 percent for African-American women.
     

Brain Cancer Statistics on Lifetime Risk

Based on rates from 2000-2002, 0.58 percent of men and women (1 in 174 men and women) born today will be diagnosed with brain cancer at some point during their lifetime. These statistics are called the lifetime risk of developing cancer. Sometimes, it is more useful to look at the probability of developing brain cancer between two age groups. For example, 0.25 percent of men will develop brain cancer between their 50th and 70th birthdays compared to 0.16 percent for women.
 

Brain Cancer Statistics on Prevalence

On January 1, 2002, in the United States, there were approximately 105,960 people (56,865 men and 49,095 women) alive who had a history of brain cancer. This includes any person alive on January 1, 2002, who had been diagnosed with brain cancer at any point prior to January 1, 2002, people with active disease, and those who had been cured of their disease.
 
Know the Signs - Concussion Safety

Cancer in Brain

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.